Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04731467
Title A Study of CM24 in Combination With Nivolumab in Adults With Advanced Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Famewave Ltd.
Indications

ovarian cancer

pancreatic adenocarcinoma

colorectal adenocarcinoma

pancreatic cancer

thyroid gland papillary carcinoma

lung non-small cell carcinoma

melanoma

Therapies

CM-24 + Nivolumab

CM-24 + Nab-paclitaxel + Nivolumab

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.